The incapacity to synthesize certain components of pulmonary surfactant causes a heterogeneous group of rare respiratory diseases called genetic disorders of surfactant dysfunction. We report a female full-term infant with neonatal respiratory distress of early onset due to inherited SP-B deficiency. The infant failed oxygen weaning at multiple trials. Chest computed tomography was performed on the 29 day of life revealing ground-glass opacities, regular interlobular septal thickening and fine interlobular reticulations. Analysis of genomic DNA showed homozygosity for an extremely rare SFTPB gene variant (c.620A>G, p.Tyr207Cys). Both parents were heterozygotes for the mutation. The diagnosis of congenital SP-B deficiency should be suspected whenever an early and acute respiratory failure in a term or near-term infant does not resolve after five days of age: diagnostic confirmation can be easily and rapidly obtained with the analysis of genomic DNA.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349626 | PMC |
| http://dx.doi.org/10.11604/pamj.2023.44.158.35316 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surfactant protein B deficiency: the RespiRare cohort.
Thorax
December 2024
Assistance Publique - Hôpitaux de Paris, Pediatric Pulmonology Department and Reference Center for Rare Lung Diseases RespiRare, Armand Trousseau Hospital, Sorbonne University, Paris, France
Childhood interstitial lung diseases (chILD) are rare and usually severe disorders. Among them, very rare cases of surfactant protein (SP)-B deficiencies have been reported so far and are usually associated with fatal forms of chILD. The RespiRare network allows the collection of precise phenotypic and genotypic information.
View Article and Find Full Text PDFMoving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant.
Am J Physiol Lung Cell Mol Physiol
December 2024
Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States.
Article Synopsis
- Research on lung surfactant has greatly improved care for preterm infants with respiratory distress syndrome (RDS), but existing animal-derived surfactants face limitations like high costs and ethical concerns.
- Synthetic lung surfactants offer advantages such as better quality, lower costs, and enhanced safety, making them a promising alternative for treating neonatal RDS.
- The combination of synthetic surfactants with nasal continuous positive airway pressure (nCPAP) can further improve respiratory outcomes, particularly in low-and-middle-income countries, by reducing the need for more invasive treatments.
Structure and Function of Canine SP-C Mimic Proteins in Synthetic Surfactant Lipid Dispersions.
Biomedicines
January 2024
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Lung surfactant is a mixture of lipids and proteins and is essential for air breathing in mammals. The hydrophobic surfactant proteins B and C (SP-B and SP-C) assist in reducing surface tension in the lung alveoli by organizing the surfactant lipids. SP-B deficiency is life-threatening, and a lack of SP-C can lead to progressive interstitial lung disease.
View Article and Find Full Text PDFPreterm birth affects both surfactant synthesis and lung liquid resorption actors in fetal sheep.
Dev Biol
February 2024
Paris-Saclay University, UVSQ, UFR-SVS, UMR1198-BREED-RHuMA, 2 avenue de la source de la Bièvre, 78180, Montigny le Bretonneux, France; Poissy St Germain Hospital, Neonatal Intensive Care Unit, Poissy, France. Electronic address:
Introduction: After birth, the lungs must resorb the fluid they contain. This process involves multiple actors such as surfactant, aquaporins and ENaC channels. Preterm newborns often exhibit respiratory distress syndrome due to surfactant deficiency, and transitory tachypnea caused by a delay in lung liquid resorption.
View Article and Find Full Text PDFA promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiency.
Mol Ther
December 2023
Department of Pathobiology, University of Guelph, Guelph, ON N1G 2W1, Canada. Electronic address:
Surfactant protein B (SP-B) deficiency is a rare genetic disease that causes fatal respiratory failure within the first year of life. Currently, the only corrective treatment is lung transplantation. Here, we co-transduced the murine lung with adeno-associated virus 6.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!